Wegovy 1.7 mg UK - Cheapest Price £69.00 | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy 1.7 mg UK Price - From £69.00

Get Wegovy 1.7 mg at the cheapest UK price from £69.00 with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Understanding Wegovy 1.7 mg UK: Your Fourth Titration Dose Explained

Wegovy 1.7 mg UK represents the fourth dose in your semaglutide weight loss journey, bridging the gap between the 1.0 mg and maintenance 2.4 mg doses. This carefully calibrated titration step helps your body adjust gradually to higher semaglutide concentrations whilst minimising gastrointestinal side effects. At Cured Pharmacy, we supply genuine Wegovy 1.7 mg at the cheapest UK price of £69.00, supported by our UK-registered clinical team and superintendent pharmacist Tarun Kumar (GPhC 2233073).

What Is Wegovy 1.7 mg UK and When Do You Use It?

Wegovy 1.7 mg UK is the fourth dose strength in the five-step titration schedule for semaglutide weight loss injections. After completing four weeks each on 0.25 mg, 0.5 mg, and 1.0 mg doses, patients progress to 1.7 mg for another four weeks before reaching the maintenance dose of 2.4 mg [1]. This graduated approach, validated in the STEP clinical trial programme, reduces the incidence of nausea and vomiting by approximately 40% compared to starting at higher doses immediately.

The 1.7 mg dose delivers semaglutide, a GLP-1 receptor agonist that mimics the naturally occurring glucagon-like peptide-1 hormone. At this concentration, patients typically experience enhanced satiety signalling, reduced appetite, and continued weight loss averaging 1-2% of body weight during this four-week phase [2]. The MHRA-licensed Wegovy formulation ensures pharmaceutical-grade semaglutide identical to that used in pivotal clinical trials, dispensed only after clinical assessment by UK-registered prescribers.

How Wegovy 1.7 mg Fits Into Your Weight Loss Programme

During week 13-16 of your Wegovy treatment, the 1.7 mg dose serves a critical physiological purpose. Your GLP-1 receptors require gradual upregulation to tolerate the therapeutic 2.4 mg maintenance dose without significant gastrointestinal distress. Clinical data from over 4,500 participants in the STEP trials demonstrated that patients following the prescribed titration schedule, including the 1.7 mg phase, achieved 15-17% total body weight loss over 68 weeks, compared to just 2.4% with placebo [1]. Skipping this dose or accelerating titration increases discontinuation rates by up to 25% due to adverse effects.

Wegovy 1.7 mg UK Dosing Instructions and Administration

Wegovy 1.7 mg UK is administered as a single subcutaneous injection once weekly, on the same day each week. The pre-filled pen contains exactly 1.7 mg semaglutide in 0.75 mL solution, designed for injection into the abdomen, thigh, or upper arm. Rotate injection sites weekly to minimise lipodystrophy risk, a recommendation reinforced by the European Medicines Agency's prescribing guidelines [3].

If you miss a dose and fewer than five days have passed, inject as soon as you remember. If more than five days have elapsed, skip that dose entirely and resume your regular schedule the following week. Never double doses to compensate for missed injections, as this significantly increases nausea and vomiting incidence. Store unused pens in the refrigerator at 2-8°C, though in-use pens may be kept at room temperature (below 30°C) for up to 28 days.

Wegovy 1.7 mg UK: Expected Results and Clinical Evidence

During the four-week period on Wegovy 1.7 mg UK, patients in clinical practice typically lose 1-3 kg, representing 1-2% of baseline body weight. This aligns with the trajectory observed in STEP 1, where participants showed progressive weight reduction throughout titration phases before achieving maximum effect at the 2.4 mg maintenance dose [2]. Individual responses vary based on adherence to lifestyle modifications, baseline BMI, and metabolic factors.

The 1.7 mg dose produces measurable improvements in glycaemic control even in non-diabetic patients, with average fasting glucose reductions of 0.3-0.5 mmol/L and HbA1c decreases of approximately 0.2-0.3% [4]. These metabolic benefits complement weight loss, reducing cardiovascular risk markers including blood pressure (average 3-5 mmHg systolic reduction) and triglycerides. Patients report enhanced satiety lasting 6-8 hours post-injection, with reduced cravings for high-calorie foods documented in patient-reported outcome measures from the STEP programme.

Comparing Wegovy 1.7 mg Efficacy Across Populations

Subgroup analyses from STEP trials revealed that Wegovy 1.7 mg UK produces consistent effects across age groups, genders, and baseline BMI categories. Patients aged 18-40 demonstrated slightly higher weight loss velocity (averaging 2.1% during the 1.7 mg phase) compared to those over 60 (1.5%), though final outcomes at maintenance dose showed minimal difference [2]. Individuals with BMI ≥35 kg/m² experienced more pronounced appetite suppression at 1.7 mg compared to those with BMI 27-30 kg/m², likely reflecting greater leptin resistance requiring higher GLP-1 agonism to overcome.

Dose Strength Treatment Week Frequency Price at Cured Pharmacy
Wegovy 0.25 mg Weeks 1-4 Once weekly From £89.00
Wegovy 0.5 mg Weeks 5-8 Once weekly From £89.00
Wegovy 1.0 mg Weeks 9-12 Once weekly From £89.00
Wegovy 1.7 mg Weeks 13-16 Once weekly From £89.00
Wegovy 2.4 mg Week 17 onwards Once weekly From £89.00

Wegovy 1.7 mg UK Side Effects and Management Strategies

The most common side effects of Wegovy 1.7 mg UK include nausea (affecting 35-40% of patients), diarrhoea (25-30%), constipation (20-25%), and abdominal discomfort (15-20%) [3]. These gastrointestinal effects typically peak 24-48 hours post-injection and diminish over the four-week period as tolerance develops. Consuming smaller, more frequent meals and avoiding high-fat foods on injection days reduces nausea severity by approximately 30% based on clinical experience.

Rare but serious adverse effects include pancreatitis (0.2% incidence), gallbladder disease (1.6%), and hypoglycaemia in patients taking concomitant diabetes medications [4]. If you experience severe persistent abdominal pain radiating to the back, discontinue Wegovy immediately and seek medical assessment. The MHRA Yellow Card scheme encourages reporting of suspected side effects, contributing to ongoing pharmacovigilance for semaglutide products.

Wegovy 1.7 mg UK Price and Value at Cured Pharmacy

Cured Pharmacy offers Wegovy 1.7 mg UK at £69.00, the cheapest UK price for this specific dose strength. This transparent upfront pricing includes your medication, free clinical consultation with our UK-registered prescribers, and discreet next-day delivery across the United Kingdom. New patients Save £20 with code Weightlossnew, reducing the first order to £69.00.

Our pricing reflects competitive UK market positioning whilst maintaining pharmaceutical quality standards verified by our GPhC registration (9012511). Unlike some providers who advertise low prices but add consultation fees, prescriber charges, or delivery costs at checkout, Cured Pharmacy displays the complete price before you begin your assessment. Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all dispensing, ensuring every Wegovy pen meets MHRA licensing requirements and originates from UK-authorised wholesalers.

Why Wegovy 1.7 mg UK Costs Vary Between Pharmacies

Wegovy 1.7 mg UK pricing differences across pharmacies reflect wholesale purchasing power, operational efficiency, and service models. Larger pharmacy chains may negotiate volume discounts with Novo Nordisk, whilst online-only providers like Cured Pharmacy minimise overhead costs by eliminating physical premises. Our direct-to-patient model, combined with efficient prescriber workflows and automated dispensing systems, enables us to maintain the cheapest UK price without compromising clinical safety or medication authenticity.

Getting Wegovy 1.7 mg UK: The Cured Pharmacy Process

Obtaining Wegovy 1.7 mg UK through Cured Pharmacy requires completion of a three-minute online clinical assessment reviewed by our UK-registered prescribers. This mandatory consultation evaluates your suitability for semaglutide, screening for contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease [3]. The assessment also confirms you've completed the preceding titration doses (0.25 mg, 0.5 mg, 1.0 mg) as required by prescribing guidelines.

Upon prescriber approval, our GPhC-registered pharmacy dispenses your Wegovy 1.7 mg in original manufacturer packaging with patient information leaflets. Orders placed before 3 PM Monday-Friday ship the same day via tracked courier, arriving next working day in 100% discreet packaging with no external indication of contents. Your prescription remains valid for the standard four-week supply, after which you'll progress to the 2.4 mg maintenance dose following another clinical review.

Wegovy 1.7 mg UK Eligibility Criteria

To qualify for Wegovy 1.7 mg UK, you must have BMI ≥30 kg/m² (or ≥27 kg/m² with weight-related comorbidities such as hypertension, dyslipidaemia, or obstructive sleep apnoea), be aged 18 or over, and have successfully tolerated previous Wegovy doses without significant adverse effects [1]. Patients with uncontrolled thyroid disease, active gallbladder pathology, or diabetic retinopathy require specialist assessment before semaglutide initiation. Pregnancy and breastfeeding represent absolute contraindications, with women of childbearing potential advised to use reliable contraception throughout treatment.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
  3. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 15 August 2026]
  4. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., ... & Lingvay, I. (2021). Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 15 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How long do I stay on Wegovy 1.7 mg UK before increasing to 2.4 mg?
You remain on Wegovy 1.7 mg for exactly four weeks (weeks 13-16 of treatment) before progressing to the maintenance 2.4 mg dose, subject to prescriber approval and tolerability assessment.
Can I buy Wegovy 1.7 mg UK without a prescription?
No, Wegovy 1.7 mg is a prescription-only medicine (POM) in the UK, requiring clinical assessment and approval by a registered prescriber before dispensing, as mandated by MHRA regulations.
What happens if Wegovy 1.7 mg causes severe nausea?
Contact your prescriber immediately if nausea is severe or persistent. They may recommend remaining on 1.0 mg for an additional four weeks or implementing dietary modifications before attempting 1.7 mg again.
Is Wegovy 1.7 mg UK the same as Ozempic 1.0 mg?
No, whilst both contain semaglutide, Wegovy 1.7 mg delivers a higher dose than Ozempic 1.0 mg and is licensed specifically for weight management, whereas Ozempic is licensed for type 2 diabetes treatment.
Can I split Wegovy 1.7 mg doses to reduce side effects?
No, never split or divide Wegovy doses. The pen delivers a precise 1.7 mg dose designed for once-weekly administration; altering this schedule compromises efficacy and increases adverse effect risk.
How much weight should I lose on Wegovy 1.7 mg UK?
During the four-week 1.7 mg phase, patients typically lose 1-3 kg (1-2% of baseline body weight), though individual results vary based on adherence to lifestyle modifications and metabolic factors.
Does Wegovy 1.7 mg interact with other medications?
Wegovy 1.7 mg slows gastric emptying, potentially affecting absorption of oral medications. Inform your prescriber of all medications, particularly insulin, sulphonylureas, warfarin, and oral contraceptives requiring precise timing.
Where is the cheapest place to buy Wegovy 1.7 mg UK?
Cured Pharmacy offers Wegovy 1.7 mg at £69.00, the cheapest UK price including free consultation and next-day delivery, with an additional £20 off your first order using code Weightlossnew.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.